ArticleNature communications2026
Adaptive oncogenesis of β-catenin emerges from declining liver tissue integrity.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
Mutations are fundamental to oncogenesis, yet they cannot fully explain cancer progression, as oncogenic mutations frequently accumulate in healthy tissues without immediate malignancy. In the liver, β-catenin mutations are highly prevalent in hepatocellular carcinoma but are widely considered weak or cooperative drivers, raising the question of how their oncogenic potential is contextually regulated. Aging and chronic injury are major determinants of cancer risk. However, how declining tissue integrity reshapes the fitness of cells harboring oncogenic mutations remains poorly understood. Here we show that mutant β-catenin as a single genetic event confers negative fitness in the healthy liver of male mice, where mutant hepatocytes fail to clonally expand and undergo progressive attrition associated with oxidative and endoplasmic reticulum stress. In contrast, as liver tissue integrity declines during chronic injury or aging, cells carrying the same β-catenin mutation clonally expand and promote tumorigenesis, a process linked with activation of the AKT-NRF2 axis. These findings demonstrate that β-catenin mutations acting as single genetic lesions are maladaptive under normal liver homeostasis but become adaptive as tissue integrity deteriorates. This tissue-level shift reshapes the oncogenic fitness landscape, relaxing the constraints that normally prevent tumor initiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.